Home »
NEWTON, Mass., Dec. 18, 2020 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial stage pharmaceutical company pioneering novel cancer therapies, today announced that the […] South San Francisco, CA — December 1, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the […] Actor Elliot Page, known for his roles in Juno and Netflix's Umbrella Academy, among others, announced on social media that he now identifies as transgender. Page, […] Coronavirus vaccine for ‘every American’ will be available by spring 2021: Azar Health and Human Services Secretary Alex Azar on coronavirus vaccine clinical trials. Two […] Colon cancer cases on the rise for people under 50, doctors say While colon cancer isn’t often diagnosed in those under 50, doctors and oncologists […] INDIANAPOLIS, Feb. 10, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the analysis performed by Washington University School of Medicine in the Dominantly Inherited Alzheimer Network […] EAST HANOVER, N.J., Feb. 11, 2020 /PRNewswire/ — Novartis announced today that the US Food and Drug Administration (FDA) accepted and granted Priority Review to capmatinib’s (INC280) […] blog_nyc-initiative_061819_main.jpg The ASPCA recently announced a groundbreaking, multi-year initiative to significantly improve the quality of life for New York City’s most vulnerable animals. Building on […]
Karyopharm Announces FDA Approval of Xpovio (selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
Genentech Announces FDA Approval of Gavreto (pralsetinib) for People With Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancers
Elliot Page, Known for His Role in ‘Juno’, Announces He Is Transgender
Trump announces CVS, Walgreens free coronavirus vaccines deal to help seniors
Drug-therapy combo cuts breast cancer recurrence risk by 25%, Eli Lilly announces
Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study
Novartis Announces MET Inhibitor Capmatinib (INC280), the First Potential Treatment for METex14 Mutated Advanced Non-Small Cell Lung Cancer, Granted Priority FDA Review
ASPCA Announces Major Commitment to Help Vulnerable Animals and Low-Income Pet Owners
Copyright © 2021